Who backs Mediar Therapeutics?
21 investors| Investor | Type |
|---|---|
| Kinled Holding | Family office |
| Sofinnova Partners | Venture capital |
| Mission BioCapital | Venture capital |
| ShangBay Capital | — |
| Pfizer Ventures | Other |
| Bristol-Myers Squibb | — |
| Novartis Venture Fund | Other |
| Viva BioInnovator | Other |
| Agent Capital | — |
| Alexandria Real Estate Equities | — |
| + 11 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Mediar Therapeutics investors
21 investors are on record for Mediar Therapeutics, including Kinled Holding, Sofinnova Partners, Mission BioCapital and ShangBay Capital. The early-stage round in Dec 2025 drew 18 investors.
Free account
More of Mediar Therapeutics with a free account
- ·The complete investor list: 21 names
- ·Watch Mediar Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 21 firms already write checks for companies like Mediar Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View